The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

The Food and Drug Administration (FDA) has approved Arbli ™, an oral suspension formulation of losartan potassium ... adults and children greater than 6 years old; for the reduction of the ...

Scienture shares originally traded higher on Tuesday but have since reversed and began trading lower after the company ...

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers ...

Scienture (SCNX) announces the U.S. Food and Drug Administration, FDA, has approved SCN-102, one of the products being developed by Scienture, ...

HOLDINGS has completed a draw on its Equity Line of Credit to support the commercial launch of Arbli Oral Suspension, while ...

I’m one of the millions of people trying to keep the weight off without taking expensive drugs like Mounjaro or Ozempic for ...

Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The Food and Drug Administration (FDA ... placebo were also observed in other secondary endpoints including the 6-minute walk test (least squares [LS] mean difference in change from baseline ...